About this event
In this webinar, you will learn about key achievements within the Recomb project, recent progress in clinical trials for RAG1-SCID, and the impact of gene therapy on quality of life and cost-effectiveness for SCID patients. Join us to explore the future of gene therapy and its potential to transform patient care.
Hosted by
IPOPI is a non-profit international organisation and the leading advocate for patients living with primary immunodeficiencies (PID) and associated conditions worldwide.
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) is an international not for profit organisation dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency (PID) patients worldwide.